Luck, Jr., James V.
December 2006
Journal of Bone & Joint Surgery, American Volume;Dec2006, Vol. 88-A Issue 12, p2563
Academic Journal
The article offers the author's views on two different studies on osteonecrosis in sickle cell disease published within the issue. Despite presenting different conclusions in terms of the follow-up medication methods, both studies established the prevalence of osteonecrosis in patients with sickle cell disease.


Related Articles

  • Call for national sickle cell database.  // British Journal of Hospital Medicine (17508460);Jun2008, Vol. 69 Issue 6, p317 

    The article reports that the British National Confidential Enquiry into Patient Outcome and Death (NCEPOD) has indicated that the serious complications of sickle cell disease that may ultimately lead to death are not well known. The NCEPOD has released the results of the first national survey on...

  • The Facts About Sickle Cell Disease.  // Ebony;Jul2006, Vol. 61 Issue 9, p70 

    Presents an interview with Dr. Willarda Edwards, president and chief operating officer of Sickle Cell Disease Association of America Inc. about sickle cell disease. Definition of sickle cell disease; Transmission of and risk factors for the development of sickle cell disease; Treatment of the...

  • β-Globin Gene Cluster Haplotype Analysis as a Predictor of Sickle Cell Disease Severity. Henry Ogedegbe // Laboratory Medicine;Sep2007, Vol. 38 Issue 9, p563 

    The origin of sickle cell disease has been traced to Africa and is due to a genetic mutation in the β-globin gene. Factors contributing to the variance in disease severity include levels of fetal hemoglobin, the presence of α-thalassemia, and the type of hemoglobin haplotype linked...

  • When Your Child Has Sickle Cell Disease.  // American Family Physician;7/15/2006, Vol. 74 Issue 2, p313 

    The article presents information on sickle cell disease in children. It is a type of blood disease inherited by children from their parents. Children with sickle cell disease are at risk to have serious infection and severe anemia. To lower the chances of children with sickle cell disease to get...

  • Ischaemic cholangiopathy and sickle cell disease. Ahmed, Mansoor; Dick, Moira; Mieli-Vergani, Giorgina; Harrison, Phil; Karani, John; Dhawan, Anil // European Journal of Pediatrics;Feb2006, Vol. 165 Issue 2, p112 

    We report a case of a 6-year-old girl of Afro-Caribbean origin, known to have sickle cell disease (SCD), with recurrent history of jaundice and abdominal pain. She was extensively investigated, including endoscopic retrograde cholangiopancreatography (ERCP), which revealed diffuse cholangiopathy...

  • Infection in Splenectomized Sickle Cell Disease Patients. Pegelow, Charles H.; Wilson, Brian; Overturf, Gary O.; Tigner-weekes, Linda; Powars, Darleen // Clinical Pediatrics;Feb1980, Vol. 19 Issue 2, p102 

    This article focuses on infection in splenectomized sickle cell disease patients. An increased risk of overwhelming bacterial infection and meningitis has been established for individuals having sickle cell anemia. Several demonstrated abnormalities may be responsible for this increase. Of 534...

  • Characterization of altered patterns of endothelial progenitor cells in sickle cell disease related pulmonary arterial hypertension. Anjum, Fatima; Lazar, Jason; Zein, Joe; Jamaleddine, Ghassan; Demetis, Spiro; Wadgaonkar, Raj // Pulmonary Circulation;2012, Vol. 2 Issue 1, p54 

    Endothelial dysfunction plays an important role in the pathogenesis of pulmonary arterial hypertension (PAH) in sickle cell disease (SCD). A variety of evidence suggests that circulating endothelial progenitor cells (EPCs) play an integral role in vascular repair. We hypothesized that SCD...

  • Sickle cell disease. Mason, Philippa // Journal of Perioperative Practice;Sep2006, Vol. 16 Issue 9, p443 

    This article explores Sickle Cell Disease and Sickle Cell Trait. These are hereditary conditions that affect thousands of people in the UK and abroad. The disease tends to occur in people of Afro-Caribbean or Mediterranean descent. The specific Pre-, Peri- and postoperative care of affected...

  • U.S. SENATE PASSES TALENT'S BILL TO TREAT PATIENTS WITH SICKLE CELL DISEASE.  // Exceptional Parent;Jul2004, Vol. 34 Issue 7, p20 

    Reports on the passage of the Sickle Cell Treatment Act of 2003 of U.S. Senator Jim Talent by the U.S. Senate. Treatment and expansion of services for patients with the blood disorder; Amendment to the JOBS Act; Potential of the legislation to increase funding for treatment and research efforts.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics